Ascendis Pharma Stock Forecast

Stock Price Forecast

According to 15 professional analysts, the 12-month price target for Ascendis Pharma stock ranges from a low of $220 to a high of $307. The average analyst price target of $256.27 forecasts a 24.74% increase in the stock price over the next year.

Price Target: $256.27 (+24.74%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$220	$256.27	$254	$307
Change	+7.09%	+24.74%	+23.64%	+49.44%

Analyst Ratings

The average analyst rating for Ascendis Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	7	6	6	7	6	6
Buy	10	10	10	10	9	9
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	16	16	17	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yun Zhong Wedbush	Wedbush	Buy Reiterates $220	Buy	Reiterates	$220	+7.09%	Nov 18, 2025
Martin Auster Raymond James	Raymond James	Strong Buy Initiates $271	Strong Buy	Initiates	$271	+31.91%	Oct 17, 2025
Li Watsek Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $203 → $254	Buy	Maintains	$203 → $254	+23.64%	Oct 13, 2025
Jessica Fye JP Morgan	JP Morgan	Buy Maintains $260 → $264	Buy	Maintains	$260 → $264	+28.50%	Oct 9, 2025
Tazeen Ahmad B of A Securities	B of A Securities	Strong Buy Maintains $227 → $230	Strong Buy	Maintains	$227 → $230	+11.95%	Sep 2, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

726.32M

from 363.64M

99.74%

from 363.64M

Revenue Next Year

1.30B

from 726.32M

79.40%

from 726.32M

EPS This Year

-3.22

from -6.53

EPS Next Year

3.16

from -3.22

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Jan 1, 2023	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	6.95M	7.78M	51.17M	266.72M	363.64M	726.32M	1.30B
Revenue Growth	-48.02%	11.87%	557.93%	421.20%	36.34%	99.74%	79.40%
EPS	-8.28	-7.00	-10.40	-8.55	-6.53	-3.22	3.16
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	55.80
No. Analysts	-	-	-	-	-	18	18

Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	764.9M	1.5B
Avg	726.3M	1.3B
Low	668.9M	1.1B

Revenue Growth

Revenue Growth	2025	2026
High	110.4%	108.0%
Avg	99.7%	79.4%
Low	83.9%	44.8%

EPS Forecast

EPS	2025	2026
High	-2.95	6.38
Avg	-3.22	3.16
Low	-3.69	-0.54

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.